tiprankstipranks
BridgeBio Pharma Inc (DE:2CL)
MUNICH:2CL

BridgeBio Pharma (2CL) Stock Investors

3 Followers
Based on 728,574 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.1% of all portfolios hold DE:2CL
On average, investors allocate 4.13% of their portfolios to DE:2CL
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 728,574 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 2CL

1.7%
Last 7
Days
18.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DE:2CL, out of 728,574 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

2CL Investor Activity

No data currently available
Based on the activity of 13,682 investors who made their portfolios public
The table shows changes in 2CL in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

2CL Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.19%
-1.26%
-3.57%
36.58B
Consumer Cyclical
Merck & Company
4.12%
-0.04%
-0.41%
317.52B
Healthcare
Marvell
4.86%
+1.81%
+7.70%
57.57B
Technology
Trade Desk
4.73%
-0.79%
-2.40%
39.18B
Technology
Block
4.49%
-1.08%
-7.00%
45.26B
Technology
ChargePoint Holdings
3.92%
-0.91%
-7.35%
592.70M
Consumer Cyclical
Micron
5.85%
+0.36%
+23.55%
128.82B
Technology
GE Aerospace
5.53%
+1.08%
+6.09%
170.19B
Industrials
Riot Platforms
4.74%
-1.51%
+0.37%
2.02B
Financial
Coherus Biosciences
2.65%
-1.32%
-8.34%
244.02M
Healthcare
Based on the activity of 728,574 active portfolios
Open your Smart Portfolio

2CL Investor Analysis

DE:2CL investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.2%
of DE:2CL holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
DE:2CL investors between 35–55

Between 35–55

4.9%
Last 30 days
Holdings Change
48.6%
of DE:2CL holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
DE:2CL investors over 55

Over 55

26.7%
Last 30 days
Holdings Change
42.2%
of DE:2CL holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of DE:2CL stock investors
See who invests in 2CL according to age group and performance.

FAQ

How many retail Investors hold DE:2CL?
0.1% of TipRanks' retail investors hold DE:2CL in their portfolios.
    What is DE:2CL Investor Sentiment?
    DE:2CL’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of DE:2CL in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of DE:2CL in the last 7 days.
        What percentage of retail investors changed their holding of DE:2CL in the last 30 days?
        ▲ 18.6% of TipRanks' retail investors changed their holding of DE:2CL in the last 30 days.
          What is the average age of retail investors who hold DE:2CL?
          The average age of DE:2CL Holders is between 35–55.
            What other stocks have DE:2CL investors also bought?
            DE:2CL Investors also bought DKNG, MRK, MRVL, TTD, SQ, CHPT, MU, GE, RIOT, CHRS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis